Algenetix Overview

  • Founded
  • 2010
  • Status
  • Acquired/​Merged
  • Employees
  • 5
  • Latest Deal Type
  • M&A

Algenetix General Information


Developer of single cell petrochemical alternatives. The company provides PhotoSeed technology, which is used for lipid productivity in industrial microbes. It also develops renewable oils that can replace petroleum for fuels and chemicals.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Environmental Services (B2B)
Other Industries
Primary Office
  • 12555 High Bluff Drive
  • Suite 175
  • San Diego, CA 92130
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Algenetix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 24-Nov-2015 00.00 Completed Startup
4. Early Stage VC (Series A1) 03-Apr-2013 000 00.00 Completed Startup
3. Early Stage VC (Series A) 15-Jan-2013 00000 00000 Completed Startup
2. Early Stage VC (Series A) 13-May-2010 Completed Startup
1. Seed Round Completed Startup
To view Algenetix’s complete valuation and funding history, request access »

Algenetix Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Algenetix Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Finistere Ventures Venture Capital Minority 000 0000 000000 0
Kapyon Ventures Venture Capital Minority 000 0000 000000 0
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
Two Oceans Family Office Minority 000 0000 000000 0
To view Algenetix’s complete investors history, request access »